DJIA 17,042.13 2.64 0.02%
NASDAQ 4,536.32 4.21 0.09%
S&P 500 1,990.52 -1.85 -0.09%
market minute promo

Integra LifeSciences (NASDAQ: IART)

49.68 0.01 (0.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IART $49.68 0.02%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.46
Previous Close $49.67
Daily Range $49.19 - $49.74
52-Week Range $37.93 - $50.25
Market Cap $1.6B
P/E Ratio -215.96
Dividend (Yield) $0.00 (0.0%)
Volume 12,026
Average Daily Volume 162,356
Current FY EPS $2.96

Sector

Healthcare

Industry

Healthcare Information Services

Integra LifeSciences (IART) Description

The Company is dedicated to improving the quality of life for patients through the development, manufacturing and marketing of cost-effective surgical implants and medical instruments. Website: http://www.integralife.com/

News & Commentary

Integra Beats on the Bottom Line

Resistance from payors over spine procedures pressures surgical technology specialist.

Integra Lifesciences Holdings Corp Stock Upgraded (IART)

Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q2 2014 Results - Earnings Call Transcrip

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q2 2014 Results - Earnings Call Transcript

Integra LifeSciences Holdings (IART) Q2 2014 Results - Earnings Call Webcast

Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $90

Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $900M

Integra Upbeat on DuraSeal Acquisition despite Tepid Q1 - Analyst Blog

Integra LifeSciences (IART): New Analyst Report from Zacks Equity Research - Zacks Equity Research R

Integra LifeSciences (IART): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Integra Lifesciences Down to Sell - Analyst Blog

Integra Lifesciences Down to Sell - Analyst Blog

Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog

Integra Lifesciences Down to Sell on Poor Q1 Segment Show - Analyst Blog

Integra Lifesciences Down to Sell on Poor Q1 Segment Show - Analyst Blog

See More IART News...

IART's Top Competitors

IART $49.68 (0.02%)
Current stock: IART
COV $88.87 (-0.17%)
Current stock: COV
$0.00 (0.00%)
Current stock:
BAX $75.58 (-0.29%)
Current stock: BAX